Overexpression of RAD21 was linked with poor disease outcome and resistance to chemotherapy in breast cancer 21, 56, while low RAD21 expression characterized metastases in oral squamous cell carcinoma 23. The gene discussed is RAD21; the disease is breast carcinoma.